-
U.S. lawmaker raises new concerns over FDA's ultra-fast drug review program
In a letter sent Tuesday, Rep. Jake Auchincloss of Massachusetts took issue with the lack of transparency in FDA's handling of the program and questioned its legal underpinnings, noting that Congress did not sign off on the plan. -
Hims & Hers launches Wegovy knockoff pill in U.S., Novo Nordisk vows to sue
Telehealth company Hims & Hers said Thursday it will launch a cheaper, off-brand version of the weight-loss pill Wegovy, just weeks after drugmaker Novo Nordisk launched its highly anticipated reformulation of the blockbuster medication.

